Background: Irritable bowel syndrome (IBS) is a stress-sensitive disorder associated
| INTRODUCTION
Resilience is characterized by the ability to maintain homeostasis against internal and external stressors, and recover from and adapt positively to stress and adversity. [1] [2] [3] [4] [5] In some disorders such as post-traumatic stress disorder (PTSD), fibromyalgia, rheumatoid arthritis, and osteoarthritis, it has been associated with positive coping and less emotional distress. 2, 6, 7 Furthermore, in a large survey of the general population in the United States, between 50% and 60% of individuals experience traumatic events, yet only 7.8% developed PTSD in their lifetime. 8 This suggests that many individuals are resilient. The study of resilience is a growing area of research that represents a shift from a vulnerability and disease-centered approach in treatment seeking populations, to an effort to identify factors that promote wellness through positive adaptations and to appreciate the full complexity of human behavior including the strengths that allow individuals to survive and grow despite adversity. Resilience has been found to be associated with structural changes in brain regions engaged in cognitive and affective processes involved in the modulation of stress and emotional responses. 9 A greater understanding of the role of resilience and its neurobiologic correlates may provide insights on the pathophysiology and vulnerability to developing a stress-sensitive disorder such as irritable bowel syndrome (IBS).
In addition, resilience measures have the potential to be predictive of symptom severity, stress responsiveness, and outcomes in IBS.
IBS is a gastrointestinal (GI) disorder characterized by abdominal pain
and associated with alterations in stool form and/or frequency. 10 Three studies measured resilience in IBS using a validated instrument, the Connor-Davidson Resilience Scale (CD-RISC). [11] [12] [13] Two of these studies were conducted in Iran and found that resilience scores were lower in IBS patients compared to healthy controls (HCs). 11, 13 However, these studies did not appear to control for neuroticism, which has been shown to be a significant predictor of resilience. 14, 15 Neuroticism is generally defined as a disposition to experience negative emotions such as anxiety, anger, sadness, guilt, and hatred. 14 A third study was conducted in Israel and included IBS patients diagnosed by a gastroenterologist without the use of symptom criteria. The authors found that lower resilience in IBS was associated with greater psychological distress and depressive symptoms.
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Thus, it is valuable to delineate an independent relationship between the resilience and IBS separate from neuroticism, negative emotionality, and psychological sensitivity to stress. Furthermore, to our knowledge, there are no studies that have evaluated the association of resilience to IBS symptom severity or stress-related biologic measures such as cortisol.
Several survey instruments measure resilience, including the CD-RISC, which is one of the more widely used resilience questionnaires.
The CD-RISC captures personal qualities embodying resilience including personal competence, tolerance of negative effect, adaptability, sense of control over one's life, and spiritual faith. 2 The Brief Resilience Scale (BRS) was developed to concisely assess resilience, specifically the ability to "bounce back" or recover from stress, as this was considered to be the fundamental definition of resilience (ie, as opposed to resistance to illness). When studying patients who are already ill, assessing the specific ability to recover may have value compared to assessing the ability to resist illness. 15 Both the CD-RISC and the BRS axis. [16] [17] [18] In addition, studies have supported a dysregulated HPA axis in IBS even in the absence of EALs. 19, 20 There are some data in the current literature suggesting that resilience can affect the response to stress, and that resilience scores are associated with changes in brain regions involved in stress responsiveness; 9,11-13 however, to our knowledge, this has not been examined in IBS in regards to symptom severity, quality of life, and physiologic markers of stress.
The aims of this study are to: (i) compare resilience in IBS patients and healthy controls (HCs) using two measures, the CD-RISC and BRS; (ii) examine the relationships between resilience and IBS symptom severity and disease-related quality of life (QOL); (iii) determine if resilience is associated with EALs and IBS status; and (iv) determine if resilience is associated with the HPA axis response to a hormone challenge. We hypothesized that resilience, as measured by CD-RISC and BRS is: (i) lower in IBS subjects compared to HCs even when controlling for neuroticism; (ii) negatively correlated with IBS symptom severity and positively correlated with IBS-QOL; (iii) lower in subjects with a history of EALs, particularly in those with IBS; and (iv) lower in subjects with a greater HPA axis response to a hormone challenge.
| METHODS

| Study subjects
Male and female participants who were at least 18 y of age and participating in studies conducted at our clinical research center between
Key Points
• Resilience is the ability to recover from and adapt positively to stress and adversity; limited studies have suggested that resilience is lower in patients with irritable bowel syndrome (IBS), a stress-sensitive disorder.
• Decreased resilience, particularly the ability to bounce back from adversity, is more prevalent in IBS patients compared to healthy controls and is associated with worse symptoms and quality of life, early life adversity and altered cortisol response.
• Future studies should focus on resilience and other factors that promote wellness and positive traits that may be associated with greater coping during adversity, less vulnerability to disease and negative outcomes, and improved treatment response. The study was approved by the UCLA Institutional Review Board, and all subjects signed a written informed consent prior to starting the study.
| Questionnaires
The Conner-Davidson Resilience Scale (CD-RISC) is a 25-item self-rated assessment developed to measure and qualify resilience as the ability to cope with stress and adversity; higher scores reflect greater resilience (score range 0-100). The CD-RISC was developed with the goal of establishing norms for resilience in the general population and clinical samples, and to assess the extent to which resilience scores change in response to treatment. Higher scores reflect greater bounce-back resilience (score range 0-5).
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IBS health-related symptoms and outcomes were surveyed using the lower scores signify poorer health-related QOL (score range 1-100).
In addition, a bowel symptom questionnaire measured the overall IBS symptom severity and abdominal pain over the past week using a 0-20 numeric rating scale (none to most intense imaginable), and usual severity of IBS symptoms (How bad are your symptoms usually? 1=none, 2=mild, 3=moderate, 4=severe, 5=very severe).
| Other psychological measures
The Early Trauma Inventory Self Report-Short Form (ETI-SR) inventories
the occurrence (before the age of 18) of 27 EAL items in the following domains: general trauma (11 items), physical (5 items), emotional (5 items), and sexual abuse (6 items). Each of the 27 items is scored as 'Yes'=1 or 'No'=0 (score range 0-27). 23 The ETI-SR has previously been used in studies of EALs in IBS.
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The Hospital Anxiety and Depression (HAD) Scale 24 measures current anxiety and depression symptoms (score range 0-21).
The Perceived Stress Score (PSS)
25 is a validated 10-item questionnaire used to evaluate the association of perceived stress over the past 1-mo with disease severity in chronic conditions (score range 0-40).
Personality Traits including neuroticism and extraversion were measured using the Mini-International Personality Item Pool (IPIP), 26 ,27 a twenty-item questionnaire measuring the Big Five factors of personality (ie, extraversion, agreeableness, conscientiousness, neuroticism, and intellect/imagination) (score range 10-50). Example items for neuroticism include "I have frequent mood swings", "I get upset easily", and for extraversion include "I am the life of the party", "I don't talk a lot"
(negatively scored).
| Hormone challenge tests
A subset of patients who completed the resilience questionnaires underwent tests to measure the HPA axis response to a hormone challenge. The results of the hormone challenge tests in a larger group of IBS and HC subjects were previously published. 
| ACTH stimulation test
The ACTH stimulation test was performed at least one week after the CRF stimulation test. IV catheters were placed into a forearm vein at 
| Statistical methods
Continuous variables were summarized as means and standard deviation and categorical variables as count (%) and simple comparison tests (ie, Wilcoxon or Chi-square tests) were used to compare differences between IBS and HCs. Linear regression analyses were used to estimate the relationships among the variables of interest and were adjusted for age, sex, and education. The regression analysis to assess whether the relationship between resilience and IBS status differed by sex was controlled for age and education.
As previously mentioned, because resilience has been shown to be negatively correlated with neuroticism in patient populations, 7, 14, 15 we tested to see if any differences between resilience and the presence of IBS remained after adjusting for neuroticism. When testing the relationships between resilience scores and GI symptom severity and IBS-QOL, we also evaluated whether PSS could affect these relationships by testing the interaction between PSS with GI symptoms or IBS-QOL on resilience. We wanted to determine if the relationships between resilience and IBS symptom severity and QOL were not mainly due to current perceived stress rather than chronic stress responsiveness.
The responses to the hormone challenge tests were analyzed by calculating the area under the curve with respect to the minimum value (AUCi) using the trapezoidal method. The rise slope was calculated using the slope of the regression line from the baseline to peak.
The decline slope was calculated using the slope of the regression line from peak to the lowest value after the peak.
Statistical analyses were conducted in SAS v. 9.4, statistical significance was assessed at the 0.05 level and all tests were two-tailed.
| Sample size calculation
We planned the sample size for our study using estimates provided 
| RESULTS
| Subject characteristics
A total of 256 subjects participated in the study, 102 were HCs (61% women, mean age=28.6) and 156 were patients with IBS (71% women, mean age=29.4) ( Table 1 ). There were no statistically significant differences between the two groups for sex, age, and education.
IBS patients had higher psychological symptom scores compared to those for HCs. 
| Resilience in IBS vs healthy controls
| Association between resilience and IBS outcomes
Among patients with IBS, increased usual symptom severity was associated with decreased resilience as measured by CD-RISC (t=−2.65,
P=0
.008) and BRS (t=−3.11, P=.002) (Figure 2 ). Lower resilience scores were also associated with poorer IBS-QOL using CD-RISC (t=3.876, P<.001) and BRS (t=4.70, P<.001) (Figure 3) . The relationships between resilience with GI symptom severity and IBS-QOL
were not different when adjusted for PSS. In other words, the associations between lower resilience and worse usual symptom severity and disease-specific QOL were not explained by having higher current perceived stress. This association was tested because higher PSS scores were associated with lower resilience scores in IBS using the CD-RISC (t=−9.343, P<.001) and BRS (t=−8.54, P<.001). There were no associations between resilience and current overall IBS symptom severity, abdominal pain, or bloating ratings.
| Association between EALs and resilience
There was a negative association between resilience scores and ETI-SR scores. An increased number of EAL events, as measured by the ETI-SR score, was significantly associated with a decreased resilience score as measured by both the CD-RISC (t=−2.65, P=.009) and BRS (t=−2.55, P=.011) across all subjects. In addition, IBS subjects had significantly lower resilience scores as measured by the CD-RISC (P=.019) and BRS (P<.001) compared to HCs after controlling for ETI-SR scores (Figure 4 ). That is, if IBS and HC subjects had experienced a similar number of EAL events, IBS subjects had lower resilience scores than HC subjects.
| Association between HPA axis response and resilience
Out of 256 subjects, 91 (37 IBS and 54 HCs) underwent the hormone challenge study and completed the resilience surveys. The clinical characteristics for this subset were similar to the larger group of IBS and HC subjects (Table 1) . There was a significant interaction between BRS resilience scores and IBS status on AUCi for ACTH-stimulated cortisol response (P=.031) ( Figure 5 ). There was also a significant interaction between CD-RISC resilience scores and IBS status for the decline slope in the recovery of cortisol to baseline after ACTH stimulation (P=.013). Less resilient HCs had a lower cortisol response to ACTH stimulation and a slower recovery to baseline compared to more resilient HCs. In contrast, less resilient IBS subjects had an enhanced cortisol response and faster recovery to baseline compared to more resilient IBS subjects. There were no significant associations between resilience scores and CRF-stimulated ACTH or cortisol response measures.
| DISCUSSION
Resilience, a measure of successful stress coping ability, plays a role in the vulnerability to and the experience of disease, and can impact response to therapy. with a history of chronic GI and pain conditions, use of psychotropic medication, or participation in psychotherapy. However, some HCs endorsed psychological symptoms, a history of EALs and/or perceived stress. Furthermore, mean CD-RISC scores of our HCs were similar or even lower than those of the general population in other studies. 2, 11 As the evolving definition of resilience is multidimensional, the BRS sought to measure resilience in its original and most basic construct, the ability to bounce back. In our study, even after adjusting for neuroticism, bounce-back resilience was a salient factor associated with IBS status, usual symptom severity, and disease-related QOL. Furthermore, the effect of resilience on disease-related severity and QOL was not due to increased perceived stress, suggesting that lowered resilience in IBS is primarily due to a decreased ability to bounce back from stress or adversity. Less resilient IBS patients had a greater severity of usual symptoms, but not for current symptoms, which is not surprising as resilience probably has a greater impact on chronic outcomes. When used in a symptomatic patient population, the BRS can assess the ability to recover, rather than to simply resist illness. From a clinical practice shown to be associated with decreased IBS symptom severity 29 and it is possible that an exercise program increases resilience as well.
We have shown that the more EALs an individual experiences, the lower their resilience tends to be; furthermore, this relationship is more prominent in patients with IBS. When HC and IBS subjects were exposed to the same number of EALs, HCs had higher resilience scores compared to those in patients with IBS, suggesting that the association of IBS with decreased resilience is independent of EALs. It is conceivable that subjects who have lower resilience go on to develop negative coping mechanisms and a hyperresponsive stress response in the face of childhood adversity, and become predisposed to disease.
To our knowledge, the association between resilience and HPA axis response has not been previously studied in IBS. We found a significant interaction between IBS status, resilience, and the stress hormone response, particularly the cortisol response to ACTH stimulation and the recovery of cortisol levels to baseline. We have previously
shown that the ACTH-stimulated cortisol response is divergent with greater responses in IBS men vs HC men and a blunted response in IBS women vs HC women. 19 In prior studies evaluating the relationship between resilience and HPA axis response, more resilient healthy individuals were found to have lower cortisol levels in response to a psychosocial stressor. 30, 31 These studies differ from ours because the hormone challenge method used in our study provides an isolated measurement of the HPA axis function, while the HPA axis response to a mental stressor task reflects changes in several components of the integrated response to stress, including inputs from the amygdala and other regions of the emotional arousal network which enhance HPA axis response. 32 We previously demonstrated that healthy individuals with low resilience have compromised cortico-limbic inhibition. Such compromised modulation of emotional responses to stress is likely associated with enhanced HPA axis responses, making such individuals more vulnerable to stressful life events. 9 IBS patients in general have decreased cortico-limbic inhibition 9, 33 and an enhanced HPA axis response 20 particularly in less resilient patients. Interestingly, IBS and HC subjects had differing relationships between cortisol response and only BRS residence scores and between cortisol recovery to baseline levels and only CD-RISC scores. These findings suggest that the ability to bounce back from stress is reflected by stress responsiveness, while the multiple facets of resilience influence one's adaptive response and ability to maintain homeostasis. However, further studies are needed to better understand and confirm these findings.
In conclusion, resilience is lower in IBS patients compared to HCs.
In addition, resilience is negatively associated with IBS symptom severity, positively associated with IBS-QOL, and negatively associated with EALs in HCs and IBS. Both the CD-RISC and BRS are useful measures of resilience in IBS, however the BRS is preferred for measuring bounce-back resilience, which was independent of neuroticism and F I G U R E 4 Association of resilience scores and EALs. An increased number of EAL events, as measured by a higher ETI-SR score, is significantly associated with decreased resilience scores using both the CD-RISC (P=.009) and BRS (P=.011). IBS subjects have significantly lower resilience scores compared to HCs when ETI-SR scores are controlled for with CD-RISC (P=.019) and BRS (P<.001) F I G U R E 5 A greater cortisol response was associated with lower BRS resilience in IBS. There was a significant interaction between BRS resilience scores and IBS status with AUCi for ACTH-stimulated cortisol response (P=.031). Less resilient HCs had a lower cortisol response to ACTH stimulation current stress. Resilience has neurobiologic correlates as it is associated with morphologic changes in brain regions involved in executive control and emotional arousal as well as an individual's response to stress. Future studies should focus on resilience and other factors that promote wellness and positive traits that may be associated with greater coping during adversity, less vulnerability to disease and negative outcomes, and improved treatment response.
